MEDTEC, the maker of the life-saving and cancer-preventing drug AZT, has reported its first profit since the company began trading in July 2017.The Australian Securities Exchange (ASX) has opened an inquiry into the company after a series of issues raised by investors, including the price it paid for the company’s stock, which is down by […]